Diabetic Kidney Disease: How Diabetes Damages the Kidneys Over Time

How does diabetes affect the kidneys?

Diabetes damages the kidneys by causing persistently high blood glucose levels that injure the tiny filtering vessels inside each kidney. Over time, this leads to diabetic nephropathy — a form of chronic kidney disease (CKD) that can progress to kidney failure if unmanaged. S.L. Raheja Hospital in Mumbai provides specialist nephrology and diabetes care for patients at every stage of this condition.

The kidneys contain approximately one million microscopic filtering units called glomeruli. Sustained high blood sugar stiffens and scars these structures, reducing their ability to filter waste from the blood. The process is gradual — often developing silently over 10 to 20 years before symptoms become apparent.

How does diabetes cause kidney disease at a cellular level?

Understanding the mechanism helps explain why blood sugar control is so critical to kidney preservation. Diabetes damages the kidneys through several interconnected pathways:

• Glomerular hypertension: High glucose causes the small arteries feeding the glomeruli to dilate, increasing pressure inside the filtering units and accelerating structural damage.
• Glomerulosclerosis: Repeated injury leads to scarring (sclerosis) of the glomeruli, permanently reducing filtration capacity.
• Proteinuria: Damaged filters allow protein — particularly albumin — to leak into the urine, a hallmark sign of diabetic nephropathy.
• Inflammation and oxidative stress: Chronic high glucose triggers inflammatory pathways that further injure kidney tissue.
• Tubular damage: Beyond the glomeruli, the tubules that reabsorb nutrients are also affected, compounding overall kidney dysfunction.

These changes are classified across five stages of diabetic nephropathy, from early hyperfiltration (Stage 1) through to established kidney failure (Stage 5), also called end-stage renal disease (ESRD).

What are the early signs of kidney damage in diabetic patients?

Diabetic kidney disease is often called a silent condition because noticeable symptoms typically appear only in later stages. Recognising early and late warning signs allows for timely intervention.

Which diabetic patients are at highest risk of kidney damage?

Not every person with diabetes develops kidney disease, but certain factors significantly raise the risk. Identifying these helps prioritise monitoring and preventive care.

• Poor long-term blood glucose control — reflected by consistently elevated HbA1c levels
• High blood pressure (hypertension) — compounds glomerular damage independently of glucose
• Long duration of diabetes — risk increases substantially after 10 or more years with the condition
• Type 1 diabetes — carries a well-established risk of CKD, particularly when onset is in childhood or adolescence
• Family history of kidney disease — genetic predisposition plays a role
• Smoking — accelerates kidney function decline in diabetic patients
• Obesity and dyslipidaemia — metabolic factors that worsen kidney stress
• Recurrent urinary tract or kidney infections — can accelerate damage in an already vulnerable kidney

Patients with diabetes who have one or more of these risk factors should undergo kidney function screening at least once a year.

What tests check kidney function in a diabetic patient?

Routine screening can detect kidney damage years before symptoms appear. The following tests are standard in the monitoring of diabetic nephropathy:

1. Urine Albumin-to-Creatinine Ratio (UACR): Detects microalbuminuria — the earliest measurable sign of glomerular damage. A ratio above 30 mg/g on two separate tests indicates kidney involvement.
2. Serum Creatinine and eGFR: Estimated Glomerular Filtration Rate (eGFR) calculated from a blood creatinine level quantifies how well the kidneys are filtering. An eGFR below 60 mL/min/1.73m² for three or more months confirms CKD.
3. HbA1c: Reflects average blood glucose over the preceding three months; directly linked to the rate of kidney damage progression.
4. Blood pressure monitoring: Hypertension both causes and accelerates diabetic kidney disease.
5. Lipid profile: Dyslipidaemia compounds cardiovascular and renal risk in diabetic patients.
6. Kidney ultrasound: Assesses kidney size and structure; may reveal scarring or obstruction.

The nephrology team at S.L. Raheja Hospital, Mahim West, Mumbai, uses these investigations to stage kidney disease accurately and guide treatment decisions.

Can kidney damage from diabetes be stopped or reversed?

Early-stage diabetic kidney disease can be slowed significantly, and in some cases early microalbuminuria may be partially reversed with optimal management. Advanced scarring, however, is not reversible. Treatment focuses on halting progression and preserving remaining kidney function.

• Blood glucose optimisation: Maintaining HbA1c within the target range recommended by your care team is the single most important intervention.
• Blood pressure control: Target blood pressure is generally below 130/80 mmHg in diabetic kidney disease. ACE inhibitors or ARBs are preferred as they also reduce proteinuria.
• SGLT-2 inhibitors: A class of glucose-lowering medications with demonstrated kidney-protective effects independent of glucose control.
• Dietary modification: Reducing sodium, moderating protein intake, and managing potassium and phosphorus as kidney function declines.
• Lipid management: Statins and other lipid-lowering agents reduce cardiovascular risk, which is elevated in CKD.
• Dialysis or transplantation: Required when kidney function falls to end-stage levels (eGFR below 15 mL/min/1.73m²).

Patients with concurrent hormonal or metabolic conditions affecting kidney health may also benefit from review by the endocrinology team alongside nephrology care.

When should a diabetic patient see a nephrologist?

A nephrologist should be consulted — rather than waiting for a routine review — in any of the following situations:

• Urine albumin-to-creatinine ratio above 300 mg/g (macroalbuminuria) on a single test, or above 30 mg/g on two tests three months apart
• eGFR below 60 mL/min/1.73m² confirmed on two measurements at least three months apart
• A rapid decline in eGFR of more than 5 mL/min/1.73m² per year
• Blood pressure that remains above 140/90 mmHg despite two or more antihypertensive medications
• Visible blood in the urine (haematuria) not explained by infection
• Swelling of the legs, ankles, or face that is new or worsening
• Serum potassium consistently above 5.5 mmol/L
• Uncertainty about medication dosing as kidney function declines

S.L. Raheja Hospital in Mumbai, located at Raheja Rugnalaya Marg, Mahim West, offers coordinated care between its nephrology and diabetes teams, enabling timely referral and integrated management for patients with diabetic kidney disease.